These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8774265)

  • 21. Plasma serotonin level after 1 day of fluoxetine treatment: a biological predictor for antidepressant response?
    Alvarez JC; Gluck N; Fallet A; Grégoire A; Chevalier JF; Advenier C; Spreux-Varoquaux O
    Psychopharmacology (Berl); 1999 Mar; 143(1):97-101. PubMed ID: 10227085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.
    Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC
    Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
    Mitchell SN; Greenslade RG; Cooper J
    Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients.
    Zhuang X; Xu H; Fang Z; Xu C; Xue C; Hong X
    Eur J Pharmacol; 2018 Sep; 834():213-220. PubMed ID: 30031795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
    Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
    Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy.
    Boyeson MG
    Stroke; 1996 Nov; 27(11):2145-6. PubMed ID: 8898832
    [No Abstract]   [Full Text] [Related]  

  • 28. Alterations on the morphology, nitric oxide synthesis and activity of platelets reproduced in rats as possible biomarkers for depression are reversed by fluoxetine.
    González-Trujano ME; Alvarado-Vásquez N; Mendoza-Sotelo J; López G; Estrada-Camarena E; Martínez-Mota L; Moreno J
    Pharmacol Biochem Behav; 2012 Aug; 102(2):349-56. PubMed ID: 22476012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine treatment to rats modifies serotonin transporter and cAMP in lymphocytes, CD4+ and CD8+ subpopulations and interleukins 2 and 4.
    Fazzino F; Urbina M; Cedeño N; Lima L
    Int Immunopharmacol; 2009 Apr; 9(4):463-7. PubMed ID: 19189865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine (Prozac) augments platelet activation mediated through protease-activated receptors.
    Dilks JR; Flaumenhaft R
    J Thromb Haemost; 2008 Apr; 6(4):705-8. PubMed ID: 18194419
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of fluoxetine on histamine content in the rat conjunctiva].
    Aslanis D; Tiligada E
    J Fr Ophtalmol; 2001 Feb; 24(2):169-71. PubMed ID: 11240489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collagen induced human platelet aggregation: serotonin receptor antagonism retards aggregate growth in vitro.
    Menys VC
    Cardiovasc Res; 1993 Nov; 27(11):1916-9. PubMed ID: 8287397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine.
    Marek GJ; Martin-Ruiz R; Abo A; Artigas F
    Neuropsychopharmacology; 2005 Dec; 30(12):2205-15. PubMed ID: 15886717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
    Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
    J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis.
    Rami M; Guillamat-Prats R; Rinne P; Salvermoser M; Ring L; Bianchini M; Blanchet X; Megens RTA; Döring Y; Walzog B; Soehnlein O; Weber C; Faussner A; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1007-1019. PubMed ID: 29567680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in voiding frequency and cystometry in the clomipramine induced model of endogenous depression and reversal with fluoxetine.
    Lee KS; Na YG; Dean-McKinney T; Klausner AP; Tuttle JB; Steers WD
    J Urol; 2003 Nov; 170(5):2067-71. PubMed ID: 14532855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
    Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
    Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of the vasospastic response to angioplasty by pretreatment with fluoxetine. A study in the atherosclerotic rabbit.
    Sigal SL; Gellman J; Anderson GM; True LD; Chen Q; Tselentakis MJ; Ling FS; Ezekowitz MD
    Arterioscler Thromb; 1993 Jun; 13(6):907-14. PubMed ID: 8499412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
    Serebruany VL; Gurbel PA; O'Connor CM
    Pharmacol Res; 2001 May; 43(5):453-62. PubMed ID: 11394937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.